Lanzhou Foci Pharmaceutical Co., Ltd., a "China Time-honored Brand" with nearly a century of pharmaceutical history, was established in Shanghai in 1929. It pioneered the concentrated pill form of traditional Chinese medicine and was the first Chinese enterprise to engage in the industrial manufacture of traditional Chinese medicine. Listed on the Shenzhen Stock Exchange in 2011, the company is dedicated to the production, contract manufacturing, and sales of traditional Chinese patent medicines and Chinese herbal materials. The Foci trademark is a China-famous trademark. As a high-tech enterprise, it currently boasts 8 R&D platforms, 467 production approval numbers, and 10 exclusive products. Foci products have always maintained a 100% market inspection pass rate. They have been exported to 32 countries and regions across the globe. For many years, the company has consistently ranked among China's top ten traditional Chinese patent medicine-exporting enterprises.